Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST LUNG CANCER, INCLUDING NSCLC AND OTHER CANCERS
Document Type and Number:
Japanese Patent JP2021168652
Kind Code:
A
Abstract:
To provide peptides, proteins, nucleic acids and cells for use in immunotherapeutic methods, in particular in the immunotherapy of cancer.SOLUTION: The present invention furthermore relates to tumor-associated T-cell peptide epitopes, alone or in combination with other tumor-associated peptides, that can for example serve as active pharmaceutical ingredients of vaccine compositions that stimulate anti-tumor immune responses, or to stimulate T cells ex vivo and transfer into patients. Peptides bound to molecules of the major histocompatibility complex (MHC), or peptides as such, can also be targets of antibodies, soluble T-cell receptors, and other binding molecules.SELECTED DRAWING: None

Inventors:
ANDREA MAHR
WEINSCHENK TONI
SCHOOR OLIVER
JENS FRITSCHE
SINGH HARPREET
CLAUDIA WAGNER
JULI LEIBOLD
COLETTE SONG
Application Number:
JP2021087277A
Publication Date:
October 28, 2021
Filing Date:
May 24, 2021
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
IMMATICS BIOTECHNOLOGIES GMBH
International Classes:
C12N15/11; A61K35/12; A61K35/17; A61K35/76; A61K38/08; A61K38/10; A61K39/00; A61K39/395; A61K48/00; A61P35/00; A61P37/04; A61P43/00; C07K7/00; C07K14/725; C07K16/28; C12N5/0783; C12N5/10; C12N15/115; C12N15/12; C12N15/63; C12P21/02; C12Q1/6869; C12Q1/6886
Domestic Patent References:
JP2010539901A2010-12-24
JP2003530067A2003-10-14
JP2013521789A2013-06-13
Foreign References:
US20070021597A12007-01-25
WO2010131748A12010-11-18
Other References:
MOL. CELL. BIOL., vol. 8, no. 4, JPN6022023385, 1988, pages 1385 - 1397, ISSN: 0005018562
Attorney, Agent or Firm:
Go Akatsu